SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001014763-20-000005
Filing Date
2020-08-12
Accepted
2020-08-12 15:43:20
Documents
34
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 6-30-2020 form10q_06302020.htm 10-Q 392088
2 EXHIBIT 31.1 6-30-2020 exhibit31-1_06302020.htm EX-31.1 9635
3 EXHIBIT 31.1 6-30-2020 exhibit32-1_06302020.htm EX-32.1 3889
  Complete submission text file 0001014763-20-000005.txt   1725624

Data Files

Seq Description Document Type Size
4 EX-101.INS 6-30-2020 amar-20200630.xml EX-101.INS 224822
5 EX-101.SCH 6-30-2020 amar-20200630.xsd EX-101.SCH 22405
6 EX-101.CAL 6-30-2020 amar-20200630_cal.xml EX-101.CAL 16007
7 EX-101.DEF 6-30-2020 amar-20200630_def.xml EX-101.DEF 149502
8 EX-101.LAB 6-30-2020 amar-20200630_lab.xml EX-101.LAB 128277
9 EX-101.PRE 6-30-2020 amar-20200630_pre.xml EX-101.PRE 157491
Mailing Address AMARILLO BIOSCIENCES INC 4134 BUSINESS PARK DRIVE AMARILLO TX 79110-4225
Business Address AMARILLO BIOSCIENCES INC 4134 BUSINESS PARK DRIVE AMARILLO TX 79110-4225 (806) 376-1741
AMARILLO BIOSCIENCES INC (Filer) CIK: 0001014763 (see all company filings)

IRS No.: 751974352 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20791 | Film No.: 201095353
SIC: 2834 Pharmaceutical Preparations